MEDICINOVA INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Medicinova Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Medicinova Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$2.85M, a 294% decline year-over-year.
  • Medicinova Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$10.3M, a 8.2% decline year-over-year.
  • Medicinova Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$8.57M, a 39.1% increase from 2022.
  • Medicinova Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$14.1M, a 38.8% decline from 2021.
  • Medicinova Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$10.1M, a 26.8% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$10.3M -$2.85M -$2.13M -294% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$8.16M -$2.63M +$244K +8.48% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-13
Q1 2024 -$8.41M -$2.75M +$163K +5.59% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-13
Q4 2023 -$8.57M -$2.06M +$942K +31.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-15
Q3 2023 -$9.51M -$723K +$2.93M +80.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$12.4M -$2.87M +$1.16M +28.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-13
Q1 2023 -$13.6M -$2.92M +$469K +13.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-13
Q4 2022 -$14.1M -$3M -$918K -44.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-15
Q3 2022 -$13.2M -$3.65M -$73K -2.04% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$13.1M -$4.03M +$255K +5.96% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$13.3M -$3.39M -$3.2M -1703% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$10.1M -$2.08M +$902K +30.2% Oct 1, 2021 Dec 31, 2021 10-K/A 2023-03-28
Q3 2021 -$11M -$3.58M +$125K +3.37% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$11.2M -$4.28M +$167K +3.75% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$11.3M -$188K +$2.53M +93.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$13.9M -$2.99M -$1M -50.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-16
Q3 2020 -$12.9M -$3.7M -$1.33M -55.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$11.5M -$4.45M -$569K -14.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-12
Q1 2020 -$11M -$2.71M +$1.98M +42.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-12
Q4 2019 -$12.9M -$1.98M -$1.78M -854% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-19
Q3 2019 -$11.2M -$2.38M +$4.4M +64.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-26
Q2 2019 -$15.6M -$3.88M -$738K -23.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-10-26
Q1 2019 -$14.8M -$4.7M -$154K -3.39% Jan 1, 2019 Mar 31, 2019 10-Q 2020-10-26
Q4 2018 -$14.7M -$208K +$1.39M +87% Oct 1, 2018 Dec 31, 2018 10-K 2019-02-13
Q3 2018 -$16.1M -$6.78M -$3.02M -80.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-25
Q2 2018 -$13M -$3.14M -$355K -12.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-10-25
Q1 2018 -$12.7M -$4.54M -$1.53M -50.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-10-25
Q4 2017 -$11.2M -$1.6M -$1.6M Oct 1, 2017 Dec 31, 2017 10-K 2019-02-13
Q3 2017 -$9.56M -$3.76M -$3.75M Jul 1, 2017 Sep 30, 2017 10-K 2019-02-13
Q2 2017 -$5.81M -$2.79M +$410K +12.8% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-13
Q1 2017 -$6.22M -$3.02M +$365K +10.8% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-13
Q4 2016 -$6.59M -$1.45K* +$1.29K Oct 1, 2016 Dec 31, 2016 10-K 2018-02-13
Q3 2016 -$6.59M -$2.84K* -$1.23K Jul 1, 2016 Sep 30, 2016 10-K 2018-02-13
Q2 2016 -$6.59M -$3.2M -$3.2M Apr 1, 2016 Jun 30, 2016 10-K 2018-02-13
Q1 2016 -$3.39M -$3.38M -$3.38M Jan 1, 2016 Mar 31, 2016 10-K 2018-02-13
Q4 2015 -$8.85K -$2.74K* -$354 Oct 1, 2015 Dec 31, 2015 10-K 2017-02-14
Q3 2015 -$8.49K -$1.61K* +$732 Jul 1, 2015 Sep 30, 2015 10-K 2017-02-14
Q2 2015 -$9.22K -$2.29K* -$165 Apr 1, 2015 Jun 30, 2015 10-K 2017-02-14
Q1 2015 -$9.06K -$2.22K* +$137 Jan 1, 2015 Mar 31, 2015 10-K 2017-02-14
Q4 2014 -$9.2K -$2.38K* -$3.42M Oct 1, 2014 Dec 31, 2014 10-K 2016-02-25
Q3 2014 $3.41M -$2.34K* +$2.23M Jul 1, 2014 Sep 30, 2014 10-K 2016-02-25
Q2 2014 $1.17M -$2.12K* +$2.78M Apr 1, 2014 Jun 30, 2014 10-K 2016-02-25
Q1 2014 -$1.61M -$2.35K* +$2.42M Jan 1, 2014 Mar 31, 2014 10-K 2016-02-25
Q4 2013 -$4.03M $3.41M +$5.85M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-12
Q3 2013 -$9.88M -$2.24M +$142K +5.97% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-12
Q2 2013 -$10M -$2.79M -$505K -22.1% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-12
Q1 2013 -$9.51M -$2.42M +$1.45M +37.4% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-12
Q4 2012 -$11M -$2.43M +$1.07M +30.5% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-27
Q3 2012 -$12M -$2.38M +$1.52M +38.9% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-27
Q2 2012 -$13.5M -$2.28M +$2.4M +51.3% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-27
Q1 2012 -$15.9M -$3.87M +$1.79M +31.6% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-27
Q4 2011 -$17.7M -$3.5M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-28
Q3 2011 -$3.89M +$1.81M +31.7% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-28
Q2 2011 -$4.68M -$347K -8.01% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-28
Q1 2011 -$5.66M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-28
Q3 2010 -$5.7M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$4.33M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.